This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2001-2012.
Location History:
- Tubingen, DE (2001 - 2003)
- Aachen, DE (2007 - 2012)
Company Filing History:
Years Active: 2001-2012
Title: Afroditi Kapurniotu: Innovator in Antibody and Peptide Research
Introduction
Afroditi Kapurniotu is a prominent inventor based in Aachen, Germany. She has made significant contributions to the fields of antibody and peptide research, holding a total of 6 patents. Her work focuses on developing innovative methods for treating and detecting diseases related to macrophage migration inhibitor factor (MIF) and amyloid formation.
Latest Patents
One of her latest patents involves Anti-MIF antibodies. This invention relates to methods for screening molecules and detecting protein-protein interactions. More specifically, it addresses methods for screening candidate drugs for treating or detecting MIF-related diseases. The invention also provides methods for identifying molecules that can dissociate or prevent the interaction between MIF and Jab1 (c-Jun activation domain binding protein).
Another notable patent is for soluble cyclic analogues of β amyloid peptide. This invention concerns a peptide that acts as an inhibitor of amyloid formation, along with its diagnostic and medical applications.
Career Highlights
Afroditi Kapurniotu is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. Her work has been instrumental in advancing the understanding of MIF-related diseases and amyloid formation.
Collaborations
She has collaborated with notable colleagues such as Herwig Brunner and Jürgen Bernhagen, contributing to a rich environment of research and innovation.
Conclusion
Afroditi Kapurniotu's contributions to science and medicine through her patents and research collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in therapeutic approaches to complex diseases.